Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 10 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Katsanos, Aristeidis H [Clear All Filters]
Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis"..
CNS Drugs. 33(3), 293-295.
(2019). Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis..
Mult Scler Relat Disord. 21, 117-119.
(2018). The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis..
PLoS One. 10(3), e0116511.
(2015). The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis..
Ther Adv Neurol Disord. 8(5), 193-202.
(2015). The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials..
PLoS One. 11(9), e0163296.
(2016). Neurological manifestations and implications of COVID-19 pandemic..
Ther Adv Neurol Disord. 13, 1756286420932036.
(2020). Optimization of risk stratification for anticoagulation-associated intracerebral hemorrhage: net risk estimation..
J Neurol. 267(4), 1053-1062.
(2020). The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage..
J Neurol Sci. 409, 116628.
(2020). Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis..
Neurology. 94(7), e657-e666.
(2020). Stroke Incidence and Outcomes in Northeastern Greece: The Evros Stroke Registry..
Stroke. 49(2), 288-295.
(2018).